Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield agitation inventory

被引:0
|
作者
Koss, E
Weiner, M
Ernesto, C
CohenMansfield, J
Ferris, SH
Grundman, M
Schafer, K
Sano, M
Thal, LJ
Thomas, R
Whitehouse, PJ
机构
[1] CASE WESTERN RESERVE UNIV, DEPT NEUROL, CLEVELAND, OH 44106 USA
[2] UNIV TEXAS, SW MED CTR, DEPT PSYCHIAT, HOUSTON, TX USA
[3] HEBREW HOME GREATER WASHINGTON, WASHINGTON, DC USA
[4] GEORGETOWN UNIV, WASHINGTON, DC USA
[5] NYU, MED CTR, DEPT PSYCHIAT, AGING & DEMENTIA RES CTR, NEW YORK, NY 10016 USA
[6] COLUMBIA UNIV, GERTRUDE H SERGIEVSKY CTR, NEW YORK, NY USA
[7] UNIV CALIF SAN DIEGO, DEPT NEUROSCI, SAN DIEGO, CA 92103 USA
[8] UNIV CALIF SAN DIEGO, ALZHEIMERS DIS COOPERAT STUDY, SAN DIEGO, CA 92103 USA
关键词
Alzheimer's Disease Cooperative Study; agitation; Alzheimer's disease; Cohen-Mansfield Agitation Inventory; longitudinal changes; reliability; temporal patterns;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
As part of the effort of the NIA Alzheimer's disease cooperative study to develop improved instruments for quantifying effects in Alzheimer's disease (AD) clinical trials, patterns of agitated behaviors were evaluated with the Cohen-Mansfield Agitation Inventory (CMAI) in 241 AD patients and 64 healthy elderly controls with valid baseline assessment on the CMAI, The test-retest reliability of the CMAI over 1 month was good (r = 0.74 to 0.92). Physically and verbally nonaggressive behaviors were most often reported, whereas physically aggressive behaviors were rare. Frequency of agitated behaviors increased with dementia severity, especially for patients with a Mini-Mental Status Exam score of 0-4. Agitation tended to increase in the evening with dementia severity for the more impaired patients. Amount of agitation did increase after 12 months in all but controls and mildly demented patients, The CMAI shows promise for evaluating a unique aspect of behavior and may be useful in assessing the effects of cognitive enhancers and other types of psychotropic drugs on behavior in dementia patients.
引用
收藏
页码:S45 / S50
页数:6
相关论文
共 50 条
  • [41] Can antidepressant medication relieve agitation in Alzheimer's disease?
    Porsteinsson, Anton P.
    Smith, Jessica S.
    Keltz, Melanie A.
    Antonsdottir, Inga M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (09) : 969 - 971
  • [42] Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review
    Ruthirakuhan, Myuri
    Lanctot, Krista L.
    Di Scipio, Matteo
    Ahmed, Mehnaz
    Herrmann, Nathan
    ALZHEIMERS & DEMENTIA, 2018, 14 (10) : 1344 - 1376
  • [43] Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction
    Senanarong, V
    Cummings, JL
    Fairbanks, L
    Mega, M
    Masterman, DM
    O'Connor, SM
    Strickland, TL
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 14 - 20
  • [44] Neurobiological alteration in agitation in Alzheimer's disease and possible interventions
    Rao, Jagadeesh S.
    Tangarife, Maria Alejandra
    Mukunda, Ram
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [45] Therapeutic touch and agitation in individuals with Alzheimer's disease
    Hawranik, Pamela
    Johnston, Pat
    Deatrich, Judith
    WESTERN JOURNAL OF NURSING RESEARCH, 2008, 30 (04) : 417 - 434
  • [46] Examining the Effects of Music Therapy on Decreasing Agitation in Alzheimer's Disease
    Hill-Wilkes, Nakesha
    Renales, Felicia
    Seibenhener, Sherry
    Jefferson, Lenetra L.
    JOURNAL OF HOLISTIC NURSING, 2024, 42 (02) : 133 - 142
  • [47] Progresses in treating agitation: a major clinical challenge in Alzheimer's disease
    Panza, Francesco
    Solfrizzi, Vincenzo
    Seripa, Davide
    Imbimbo, Bruno P.
    Santamato, Andrea
    Lozupone, Madia
    Prete, Camilla
    Greco, Antonio
    Pilotto, Alberto
    Logroscino, Giancarlo
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2581 - 2588
  • [48] Citalopram for agitation in Alzheimer's disease: Design and methods
    Drye, Lea T.
    Ismail, Zahinoor
    Porsteinsson, Anton P.
    Rosenberg, Paul B.
    Weintraub, Daniel
    Marano, Christopher
    Pelton, Gregory
    Frangakis, Constantine
    Rabins, Peter V.
    Munro, Cynthia A.
    Meinert, Curtis L.
    Devanand, D. P.
    Yesavage, Jerome
    Mintzer, Jacobo E.
    Schneider, Lon S.
    Pollock, Bruce G.
    Lyketsos, Constantine G.
    ALZHEIMERS & DEMENTIA, 2012, 8 (02) : 121 - 130
  • [49] The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease
    Creese, Byron
    Da Silva, Miguel Vasconcelos
    Johar, Iskandar
    Ballard, Clive
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (06) : 461 - 467
  • [50] Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease
    Wang, Hui Jue
    Chinna-Meyyappan, Arun
    Feldman, Oriel J.
    Lanctot, Krista L.
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (03) : 289 - 303